Air Products (APD)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
Research Workspace
Put APD beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Materials: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Full-year adjusted EPS of $13.12 in fiscal 2026: FY26 EPS guidance $13.44 vs $13.12 target.
View ThesisRevenue is growing steadily — about 5% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 32%, softest on free-cash-flow margins.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 21% growth a year, above the roughly 6% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAPD's growth depends on large-scale clean energy projects and multi-decade agreements. Revenue growth is expected to accelerate as these projects come online. Revenue grew 9% year over year, and the last quarter beat expectations. APD trades at 23× P/E versus a 17× peer median. The market is pricing in more growth than we forecast. If APD cuts guidance on the next call, that would be negative. The thesis has broken because full-year adjusted EPS guidance is below target. Peer multiples imply a price about 21% below where it trades.
Trailing returns as of 2026-09-04. APD is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 21 analysts currently covering APD (as of Sep 2026).
Based on 6 Wall Street analysts offering 12-month price targets for APD in the last 4 months.
Continue this research
Compare APD with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| APD Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Materials (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put APD next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Raise full-year adjusted EPS guidance
S&P's stable outlook supports EPS growth expectations.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $301.27
The last 12 months of price, then the range of analyst 12-month targets from today’s $301.27.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Maintain capital expenditures at $4 billion
Facility expansion supports capital expenditure objectives.
Price target increase reflects positive earnings outlook.
Threatens: Maintain capital expenditures at $4 billion
CapEx discipline concerns could impact spending objectives.
Growth in industrial gas and semiconductor demand supports growth objectives.